mTOR inhibition as a novel gene therapeutic strategy for diabetic retinopathy

In addition to laser photocoagulation, therapeutic interventions for diabetic retinopathy (DR) have heretofore consisted of anti-VEGF drugs, which, besides drawbacks inherent to the treatments themselves, are limited in scope and may not fully address the condition’s complex pathophysiology. This is...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Steven Hyun Seung, Lee, Joo Yong, Choi, Jun-Sub, Kim, Hee Jong, Kim, Jin, Cha, Seho, Lee, Kyoung Jin, Woo, Ha-Na, Park, Keerang, Lee, Heuiran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202865/
https://www.ncbi.nlm.nih.gov/pubmed/35709240
http://dx.doi.org/10.1371/journal.pone.0269951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202865/
https://www.ncbi.nlm.nih.gov/pubmed/35709240
http://dx.doi.org/10.1371/journal.pone.0269951

Ejemplares similares